Monthly Archives: July 2015

Platinum Communications Corporation Reports Financial Results for the Nine Months Ending May 31, 2015

CALGARY, AB / ACCESSWIRE / July 16, 2015 / Platinum Communications Corp. (TSX VENTURE: PCS) today announced financial results for the nine months ending May 31, 2015.

Highlights for the nine months, include the following:

– Platinum’s revenues from operations for the nine months ending May 31, 2015 remained unchanged compared to the same nine month period of fiscal 2014. The corporation’s commercial revenues increased 32% while its residential revenues decreased 12% as a result of the increased focus on enterprise customers.
– Gross profit also remained flat. Earnings before interest, tax, depreciation and amortization decreased due to increased costs from the Pathcom acquisition for nine months in 2015
compared to five months in fiscal 2014.
– Cash provided by operating activities was $965,838 in Q3 2015 compared to $867,738 in the same quarter of fiscal 2014, an increase of 11%. Platinum recorded Net Income of $45,030 for the first nine months of fiscal 2015 a decrease of 78% over the net income recorded in the same period of the previous year.

SELECTED HIGHLIGHTS(1)

Nine months ended May 31,

2015

2014

%
Change

Revenue

$7,620,976

$7,602,233

0

Gross profit (2)

4,663,705

4,653,478

0

Earnings before interest, tax, depreciation and amortization (3)

1,521,315

1,670,854

-9

Net income

45,030

201,519

-78

Earnings per share, basic and diluted

Cash provided by operating activities

0.0008

965,838

0.0035

867,738

-77

11

ARPU(Average revenue per user)

705

627

13

Common Shares Outstanding

Return on Equity

57,019,877

0.8%

56,448,449

3.6%

1

-78

After concluding its due diligence Platinum will not be proceeding with the previously announced acquisition of the operating assets of Ironclad TEK (Ironclad). Platinum remains committed to providing a full service information/data/communication package to the commercial and enterprise market.

Platinum is a leading provider of superior quality fixed wireless Internet and Broadband solutions in Alberta. Based in Calgary, Platinum operates a wireless broadband network that utilizes Next-Generation Wimax technology to bring fast, reliable and affordable Internet and digital phone service to residents and businesses across the province. Serving approximately 10,000 customers in over 180 communities, Platinum caters primarily to rural and near-urban markets that are often beyond the reach of traditional Internet providers. Platinum’s high quality infrastructure, excellent service record and ever-growing network and capabilities, make it the provider of choice for customers within its vast coverage area. For more information please visit our website at www.platinum.ca or call 403-301-4591.

(1) Includes the previously announced acquisitions of Hybrid and Pathcom customers from November 1, 2013 and January 1, 2014 respectively.
(2) Gross Profit is a widely accepted measure of financial performance used by some analysts and investors to analyze and compare companies on the basis of operating performance. Gross profit is not defined under IFRS and should not be considered in isolation or as an alternative to, or more meaningful than, net income or cash flow as determined in accordance with IFRS as an indicator of the Corporation’s performance or liquidity. Platinum’s gross profit is unlikely to be comparable to similar measures presented by other companies.
(3) Earnings before interest, tax, depreciation and amortization is a widely accepted financial indicator used by some analysts and investors to analyze and compare companies on the basis of liquidity. Earnings before interest, depreciation and amortization is not defined under IFRS and should not be considered in isolation or as an alternative to, or more meaningful than, net income or cash flow as determined in accordance with IFRS as an indicator of the Corporation’s financial performance or liquidity.

This news release may contain forward-looking statements. These forward-looking statements do not guarantee future events or performance and should not be relied upon. Actual outcomes may differ materially due to any number of factors or uncertainties, many of which are beyond Platinum’s control. Some of these risks and uncertainties may be described in Platinum’s corporate filings (posted at www.sedar.com). Platinum has no intention or obligation to update or revise any forward-looking statements due to new information or events.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

For further information please contact:

Bernard Parkinson, CEO
Phone (403) 301-4590

Katherine Kirkup, CFO
Phone (403) 301-4594

Platinum Communications Corporation (PCS) http://www.platinum.ca

SOURCE: Platinum Communications Corporation

ReleaseID: 430615

Spherix Announces Registered Direct Common Stock and Warrant Offering

BETHESDA, MD / ACCESSWIRE / July 16, 2015 / Spherix Incorporated (NASDAQ: SPEX) an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that it has entered into definitive agreements with certain institutional investors to sell an aggregate of 5,719,532 units, with each unit consisting of (i) one share of its common stock, par value $.0001 per share (“Common Stock”) and (ii) one warrant to purchase 1.23 shares of Common Stock, in a registered direct offering for gross proceeds of approximately $1.5 million excluding the exercise of any Warrants issued in the offering, before deducting placement agent’s fees and estimated offering expenses. The per share exercise price of the warrants is $.43. The warrants are exercisable beginning on the date that is six months and one day following the closing of this offering and will expire on the date that is five and one half years from the date of closing.

The securities described above are being offered directly by Spherix Incorporated pursuant to an effective shelf registration statement on Form S-3 which was previously filed with the Securities and Exchange Commission. The closing of this offering is expected to occur on or about July 21, 2015, subject to the satisfaction of customary closing conditions.

Chardan Capital Markets LLC served as the sole placement agent for the offering. Copies of the prospectus supplement, containing a more detailed explanation of the offering and the securities, and accompanying base prospectus relating to the offering may be obtained from the Securities and Exchange Commission website at http://www.sec.gov.

This press release does not and shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities, nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state or jurisdiction.

About Spherix

Spherix Incorporated was launched in 1967 as a scientific research company. Spherix is committed to advancing innovation by active participation in the patent market. Spherix draws on portfolios of pioneering technology patents to partner with and support product innovation.

Forward-Looking Statements

Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company’s filings with the Securities and Exchange Commission (the “SEC”), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Contact:

Investor Relations:

Hayden IR
Brett Mass, Managing Partner
Phone: (646) 536-7331
Email: brett@haydenir.com
www.haydenir.com

Spherix:

Phone: (703) 992-9325
Email: info@spherix.com
www.spherix.com

SOURCE: Spherix Incorporated

ReleaseID: 430632

Pacific Bay Signs Jade Mining Agreement, $500,000 Financing Arranged, Appointment of Director

VANCOUVER, BC / ACCESSWIRE / July 16, 2015 / David H. Brett, President and CEO, Pacific Bay Minerals Ltd. (TSXV: PBM) (“Pacific Bay” or the “Company”) reports that the Company has signed a Joint Venture Agreement with Dease Lake Jade Mine Ltd. (“Dease Lake Jade”) whereby Pacific Bay will advance $500,000 to fund and participate on a 50/50 basis in the 2015 proceeds of jade mining operations on claims owned by Dease Lake Jade in Northern British Columbia (the “JV”). In connection with the JV, the Company has arranged a $500,000 private placement of 10,000,000 common shares at $0.05 per share with one investor, a BC corporation owned by Alan Qiao and Jun Qiao (the “Financing”). Both the JV and the Financing are subject to TSX Venture Exchange acceptance. The Financing will also be subject to shareholder approval as the issuance of the shares would effect a change of control of the Company. The Company intends to seek shareholder approval by consent in writing from shareholders holding greater than 50% of the outstanding shares.

In connection with and on closing of the Financing, Pacific Bay will appoint to its board of directors Mr. Alan Qiao, CEO of Dease Lake Jade. In addition, the investors in the Financing have the right to appoint one additional director (two in total) at the next annual general meeting of the shareholders of the Company. The investors have also agreed to vote the shares to be acquired under the Financing in favour of all management recommendations, subject to certain limitations, for a period of one year.

Under the JV, Dease Lake Jade, whose operations in BC have been the subject of the Discovery Channel reality TV series “Jade Fever,” will contribute access to its claims, mining infrastructure and equipment, while Pacific Bay will provide $500,000 is working capital and expert oversight of the Company’s new strategic partner Jedway Enterprises Ltd. Jedway has over 25 years of experience in Jade mining and marketing in BC. Dease Lake Jade and Pacific Bay will jointly market any jade produced in 2015 and each be entitled to a 50% share of any proceeds. Pacific Bay will have the right to extend the JV for up to 5 consecutive seasons of Jade mining jade mining by contributing additional funds to the JV for working capital on an annual basis.

The jade mining activities will be managed by a joint venture management committee with equal participation from Dease Lake Jade and Pacific Bay. Jedway will represent Pacific Bay as an onsite operation monitor of the JV.

“This transaction will propel Pacific Bay into the exciting field of Canadian jade exploration and mining in a region that the Company already has substantial mineral assets and management has decades of exploration and mining experience,” said Pacific Bay CEO David Brett. “Pacific Bay’s vision is to become a leading jade explorer, miner and exporter in Canada. The Company is actively considering acquiring additional jade mining and exploration rights in BC.”

“I look forward to working with the Pacific Bay team to capitalize on the exciting potential of BC jade exploration and mining,” said Alan Qiao, CEO of Dease Lake Jade. “The interest in BC jade in China is strong and growing.”

Pacific Bay Minerals Ltd.
Per/
David H. Brett, MBA,
President & CEO
604-682-2421

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Pacific Bay Minerals Ltd. 

ReleaseID: 430640

Klondike Gold Yukon Exploration Update

VANCOUVER, BC / ACCESSWIRE / July 16, 2015 / Klondike Gold Corp. (“Klondike Gold” or the “Company”) (TSX VENTURE: KG) is pleased to provide an update on 2015 exploration programs on the Lone Star and Dominion Properties near Dawson, Yukon Territory. The announced $800,000 exploration program (see press release February 24, 2015) commenced in late April 2015 (see press release April 30, 2015) and is currently under budget and approximately one month ahead of planned schedule. Klondike Gold owns a 100% interest of 1,406 quartz claims and 14 crown grants covering 250 square kilometers underlying the western half of the Klondike placer goldfields.

In May, Klondike Gold engaged GroundTruth Exploration Ltd (“GroundTruth”) of Dawson, YT as contractor for geophysical and orthophoto surveying. To date a total of 94.3 square kilometers of orthophotography and digital elevation modelling collected by unmanned aerial drone (“UAV”) surveying has been acquired, processed, and rectified to a UTM projection mapping base. The imagery covers the Lone Star and Dominion Properties, as well as the Indian River/McKinnon Creek placer property. The high resolution imagery is an invaluable aid to prospecting and other geoscience surveys. Additional orthophoto surveys are planned.

A total of 677 line kilometers of detailed high-sensitivity ground magnetics surveying over all high-priority areas has been acquired and processed. Magnetics surveying is complete at the Dominion and Lone Star Properties. Additional magnetic surveys are planned for the Sulphur Creek and Gold Run Properties.

Mapping and rock sampling has also been completed at Dominion Property and is well advanced at the Lone Star Property. Potential drill targets have been identified at both properties. Plans for a 2015 drill program are currently in progress.

Dominion Property Results

Magnetics surveying was completed first at the Dominion Property, combined with orthophotography, and used as a mapping and prospecting base for systematic evaluation of trenches and outcrops. Mapping of all trenches was completed in late June and 154 rock grab samples from quartz veins throughout the entire property were collected and assayed during this work. Assays from individual mineralized veins range between 0.2 g/t gold to a high of 48 g/t gold and 50 g/t silver to a high of 509 g/t silver. (This sampling is deliberately selective in nature; systematic test results may vary significantly. A “nugget effect” is evident.) These results, when combined with 2014 sampling (see press release January 19, 2015), continue to show a focussed target area of interest of some 850 meters by 200 meters extent in the central portion of the Dominion Property. Work to date shows this target contains an outcropping array of gold-mineralized quartz veins, sporadically with visible gold, and with individual veins ranging from 0.1 meters to 3.0 meters in thickness. The area has not been diamond drill tested. Interpretation of integrated mapping, magnetic surveying, rock sampling, and structural models is in progress with the intention of defining specific drill targets.

A compilation map of significant (>1 g/t Au) gold assay results for Dominion Property rock grab samples is posted to the Company’s website here (CLICK HERE).

Lone Star Property Progress

Orthophotography surveying is complete and all data has been received. A total of 500 line kilometers of magnetic surveying is complete with 75% of data received. Mapping and sampling is in progress. To date a total of 260 rock samples have been submitted for assay with results pending. Two areas of outcropping quartz veining exhibiting visible gold have been identified and are being developed as drill targets contingent upon positive assays. Specific evaluation using detailed induced polarization (“IP”) chargeability/resistivity surveying has begun on these two targets. Other areas of subcropping quartz vein material also containing visible gold are currently being investigated.

A Class 3 quartz mining land use plan (“MLUP”) permit has been received for the Lone Star Property. The term of the permit is for 5 years expiring July 2020. The Class 3 MLUP permit allows Klondike Gold to conduct advanced exploration activities subject to various conditions including mitigation measures, remediation requirements, and archeological and ecological provisions among others.

Klondike Gold has completed remediation of a 600 meter long trenched area, the “JF” trench, on the Lone Star Property originally excavated some 10 years ago. The Company plans additional remediation of old disturbed areas in conjunction with systematic exploration.

McKinnon Creek Placer

Work also continues at the McKinnon Creek placer property operated under lease for the second year by Todd Hoffman known as “316 Mining”. Under the terms of the lease, Klondike Gold receives a 20% gross (15% net) production royalty which in 2014 netted 202 ounces of placer gold to the Company. The McKinnon Creek placer mining operation is featured on the Discovery Channel show “Gold Rush”. Season 6 of Gold Rush is currently being filmed for broadcast during the fall of 2015.

Geotechnical Information

Klondike Gold samples described herein are selective in nature, non-representative rock grab samples of bedrock or boulders collected to test for the presence or absence of gold and other ‘economic’ minerals. Systematic additional test results may vary significantly. Samples are usually 0.5 kg to 2.0 kg in weight. The Company’s samples are spatially located to within 5 meters using a hand-held Global Positioning System (“GPS”) in NAD83 datum, assigned a unique assay tag, described, photographed using a GPS-enabled camera, then placed in a plastic bag and sealed. Groups of sealed sample bags are aggregated in large fiber bags then security sealed for shipment. The fiber bags were retained in locked storage in the Company’s Dawson office before being delivered by Company personnel directly to the lab. Samples were submitted to Bureau Veritas Mineral Laboratories (“BV Labs”) (formerly Acme Labs) preparation facility in Whitehorse, YT with chemical analysis of sample pulps completed in Vancouver, British Columbia. Bureau Veritas Labs is an accredited ISO 9001:2008 full-service commercial laboratory.

As per Klondike Gold’s instructions, at BV Labs each 1 kg rock sample is crushed to 80% passing 2 mm size. A 250 g subsample is pulverized to >85% passing -75 microns size (Code PRP70-250). A 30 g (1 assay ton) subsample is assayed for gold by fire assay (“FA”) fusion with an atomic absorption (“AA”) finish (Code FA430). All over-limit results in excess of 10 ppm (10 g/t) for both silver and gold are re-assayed. The re-assay uses a 30 g subsample and is assayed by FA with a gravimetric finish (Code FA530-Au/Ag). Samples were also analyzed for multi-element chemistry by ICP-MS analysis (AQ200+U code). Samples over-limit in lead are rerun by a high-detection limit ICP-ES procedure (Acme code MA370).

In addition to analyses of Klondike Gold’s rock samples, analyses were completed on 18 duplicates, 32 blanks, 21 Au-only standards, 18 Ag standards, and 28 ICPMS standards as part of QA/QC process.

The technical and scientific information contained within this news release has been reviewed and approved by Peter Tallman, P.Geo, President of Klondike Gold Corp., and Qualified Person as defined by National Instrument 43-101 policy.

ABOUT KLONDIKE GOLD CORP.

Klondike Gold Corp. is a Canadian exploration company with offices in Vancouver, British Columbia, and Dawson City, Yukon Territory. The company is focused on exploration and development of its Yukon gold projects located in the historic Klondike region covering 25,000 hectares of hard rock and 2,000 hectares of placer claims including “McKinnon Creek” leased to Todd Hoffman/Jerusalem Mining LLC and featured on the Discovery Channel show “Gold Rush”.

On behalf of Klondike Gold Corp.

“Peter Tallman”

President and CEO
(604) 559-4440
E-mail: info@klondikegoldcorp.com
Website: www.klondikegoldcorp.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Disclaimer for Forward-Looking Information

“This press release contains “forward-looking information” and “forward-looking statements” within the meaning of applicable securities laws. This information and statements address future activities, events, plans, developments and projections. All statements, other than statements of historical fact, constitute forward-looking statements or forward looking information. Such forward-looking information and statements are frequently identified by words such as “may,” “will,” “should,” “anticipate,” “plan,” “expect,” “believe,” “estimate,” “intend” and similar terminology, and reflect assumptions, estimates, opinions and analysis made by management of Klondike in light of its experience, current conditions, expectations of future developments and other factors which it believes to be reasonable and relevant. Forward-looking information and statements involve known and unknown risks and uncertainties that may cause Klondike’s actual results, performance and achievements to differ materially from those expressed or implied by the forward-looking information and statements and accordingly, undue reliance should not be placed thereon. Risks and uncertainties that may cause actual results to vary include but are not limited to the availability of financing; fluctuations in commodity prices; changes to and compliance with applicable laws and regulations, including environmental laws and obtaining requisite permits; political, economic and other risks; as well as other risks and uncertainties which are more fully described in our annual and quarterly Management’s Discussion and Analysis and in other filings made by us with Canadian securities regulatory authorities and available at www.sedar.com. Klondike disclaims any obligation to update or revise any forward-looking information or statements except as may be required.”

SOURCE: Klondike Gold Corp.

ReleaseID: 430619

AndeanGold Announces Appointment of Executive Officer

VANCOUVER, BC / ACCESSWIRE / July 16, 2015 / AndeanGold Ltd. (TSXV: AAU) (BVL: AAU) (“the Company” or “AndeanGold“) wishes to announce that Mr. John M. Siriunas, M.A.Sc., P.Eng., géo, has been appointed as the Vice President — Administration and Exploration for the Company.

Mr. Siriunas, a “Qualified Person” per the definition of National Instrument 43-101, brings over thirty-five years of exploration and junior-mining company management experience to AndeanGold; his resumé includes extensive experience working in Perú and Chile.

Mr. Alexander Peña B., CEO and President of the Company, remarked “We welcome the addition of expertise that Mr. Siriunas brings to the management of our Company, on both sides of the coin: not only outstanding geotechnical knowledge, but management skills needed to assist in the operation of a junior mining company. AndeanGold looks forward to a renewed campaign toward the development of its premier mineral properties in South America with the support of Mr. Siriunas”.

About AndeanGold Ltd:

AndeanGold Ltd. is engaged in the acquisition, exploration and potential development of base- and precious-metals properties, principally in Perú and Ecuador. The focus of the Company’s current exploration activities is in advancing its Urumalqui Project in La Libertad, Perú.

In Ecuador, the Company’s activities have been limited to maintaining its three properties in good standing. Please refer to AndeanGold’s website at www.andeangoldltd.com or information posted at www.sedar.com for further information on the Company’s projects and activities.

AndeanGold Ltd. trades with symbol AAU on the TSX Venture Exchange and currently has 112,046,579 shares outstanding (132,987,757 fully diluted).

On Behalf of the Board of Directors of
ANDEANGOLD LTD.
Alexander Peña Böttcher
CEO and President

FOR FURTHER INFORMATION PLEASE CONTACT the CORPORATE OFFICE:
Alexander Peña, AndeanGold Ltd.
Phone: (51) 94020.8400 | (51) 1.252.4407
Email: alexander@andeangoldltd.com
Skype: alexander.pena.bottcher
Website: www.andeangoldltd.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: AndeanGold Ltd. 

ReleaseID: 430638

Paramount Builders (Virginia Beach) Receives GAF’s Prestigious 2014 President’s Club Award

Paramount Builders of Virginia Beach, VA, has received GAF’s 2014 President’s Club Award. A GAF Master Elite(R) contractor since 2012, it has become the Mid-Atlantic’s leading roofer and exterior remodeler, with seven locations statewide.

Virginia Beach, VA – July 16, 2015 – Paramount Builders, Inc., of Virginia Beach, Virginia, has received GAF’s most prestigious contractor award: The GAF President’s Club Award. This highly coveted award recognizes Paramount Builders as one of the “elite of the elite” residential roofing contractors in the United States.

GAF is North America’s largest roofing manufacturer, and only GAF Master Elite(R) Contractors can compete for its President’s Club Award. To qualify for this award, a contractor must demonstrate an exceptional level of excellence in their business, especially in the areas of Installation Excellence, Consumer Protection, and Installer Training.

Paramount Builders has been a GAF Master Elite(R) Contractor since 2012. To become a Master Elite(R) Contractor — a status that less than 2% of roofing contractors nationwide have achieved — a candidate must demonstrate proper licensing and adequate insurance, have a proven reputation and show commitment to ongoing professional training.

Paramount Builders is a classic “local boy makes good” story. In 1991, owner Ed Augustine started the company from his apartment. “He grew the business as he saw fit,” according to Sales and Marketing Assistant, Katie Wylie. “He borrowed a small amount of money, and started the company,” adds Bob Shackford, Vice President of Operations. “Ed was working for another remodeling company at the time but didn’t like the way they did things — he wanted to set a higher standard. And Paramount Builders was born. He chose that name because he wanted it to be the pinnacle of the industry.”

Since then, Paramount has grown into a multimillion-dollar company with seven locations in Virginia. “We’re the largest home-improvement company in the state,” says Shackford. “Having multiple locations has enabled us to cover a vast territory. We have the name recognition and relationships with the customers — they know they can call us, and we’ll still be around down the road. We have longevity as a business and an established management team, including several employees that have been with us from day one.”

Paramount is deeply involved in organizations across the state. “The owner makes it a priority to give back to the community,” says Wylie. “For example, we did a social media drive last year — we gave away a total of $5,000 to five different charities that were selected by fan votes on our Facebook page. We donated to the Virginia Wounded Warrior program, the Wish-a-Fish Foundation in Tidewater, Hope Charitable Services in Portsmouth, Children’s Hospital of The King’s Daughters hospital in Norfolk, and NAMI.” Also supporting local churches, homeless shelters, and children’s sports teams, Paramount has provided a new scoreboard and jerseys for the Lynnhaven Little League.

The company is involved with professional organizations as well, including the National Association of Home Builders, the National Association of the Remodeling Industry, Virginia Association of Professional Roofers the Home Building Association of Richmond, and the Tidewater Builders Association. At all locations, Paramount maintains an A+ accreditation from the Better Business Bureau; it has been recognized as “Best Place to Work” in Hampton Roads and has won multiple “Best of the Beach” awards.

The future looks bright for Paramount, with continued growth and expansion into new territories. “We’re looking into the western part of Virginia, and we’re growing in the northern part of the state,” says Shackford. He concludes: “We went into this business with a goal, all those years ago. We were babes in the woods but we continued to do the right things and how to make the wrong things right. We’ve just continued to grow since then, because of our employees, installers and relationships with established manufacturers.”

About Paramount Builders

The Mid-Atlantic’s leading provider of replacement windows, vinyl siding, trim, roofing and doors, Paramount Builders maintains the goal of establishing the highest standard of excellence in the industry. Paramount sells not only the finest exterior remodeling products but its family, its reputation, and its commitment to excellent customer service — before, during, and after installation — and its products are backed by the best warranties in the industry.

For more information, visit:

Website: http://www.paramountbuilders.com
Facebook: https://www.facebook.com/ParamountBuilders
Twitter: https://twitter.com/ParamountBuild
YouTube channel: https://www.youtube.com/user/ParamountBuildersInc

About GAF

Founded in 1886, GAF has become the largest roofing manufacturer in North America. The company’s products include a comprehensive portfolio of steep-slope and commercial roofing systems, which are supported by an extensive national network of factory-certified contractors. Its success is driven by its commitment to Advanced Quality, Industry Expertise, and Solutions Made Simple for contractors, specifiers, and property owners alike. In 2011, GAF was the first roofing manufacturer to offer a Lifetime limited warranty on all of its laminated shingles and, in 2012, it introduced the GAF Lifetime Roofing System.

For more about GAF, visit: http://www.gaf.com

Media Contact
Company Name: Paramount Builders, Inc.
Contact Person: Katie Wylie
Email: kwylie@pbiva.com
Phone: (757) 340-9000, Toll-free: (888) 340-9002
Address:501 Central Drive
City: Virginia Beach
State: VA
Country: United States
Website: http://www.paramountbuilders.com

ReleaseID: 506083


Source: GetNews

UCLA Bruins Football Tickets: CapitalCityTickets.com is Slashing Ticket Prices on all UCLA Bruins Football NCAA Regular Season Home Game Tickets at the Rose Bowl

CapitalCityTickets.com is slashing their prices on NCAA tickets to see the UCLA Bruins live at the Rose Bowl during the 2015 season. Bruins’ fans can save on already slashed ticket prices by using promo code CITY5 to save 5% on all orders.

UCLA Bruins NCAA tickets are always a popular and highly searched for sports ticket. CapitalCityTickets.com stocks all levels of seating and price ranges to see the UCLA Bruins play!

Finding cheap and affordable UCLA Bruins Football tickets can be a tiresome experience. They offer a very safe online buying experience for UCLA Bruins Football tickets.

Save time and money with CapitalCityTickets.com

Does CapitalCityTickets.com have UCLA Bruins Football Tickets?

CapitalCityTickets.com carries UCLA Bruins Football tickets as well as seating charts and venue maps for all UCLA Football games. If you need more information on UCLA Bruins Football tickets, event parking passes, etc. call CapitalCityTickets.com toll-free at 855-514-5624.

How do I purchase UCLA Bruins Football Tickets from CapitalCityTickets.com?

Click on the link “view tickets” to pick your UCLA Bruins Football tickets. Purchasing UCLA Bruins Football tickets online has never been easier.

BROWSE HERE for a wide selection of UCLA Bruins NCAA tickets.

If you would like to attend a Bruins game live in person, CapitalCityTickets.com is your source.

Save money with CapitalCityTickets.com already slashed tickets prices and by using promo code CITY5 to save an additional 5% on all orders.

Follow on Facebook at: http://www.facebook.com/CapitalTickets

CapitalCityTickets.com
Live Customer Support
Order by Phone Toll Free 7 Days a Week
(855) 514-5624

Browse the inventory of tickets for the UCLA Bruins at the Rose Bowl today and save! http://www.capitalcitytickets.com/UCLA-Bruins-Football-Tickets

Disclaimer: CapitalCityTickets.com is not associated with any artists, teams, venues, organizations, institutions, bands, or artists featured on their website in any way. Also, any names or titles used in this press release are solely for descriptive purposes and do not imply, indicate, or suggest any type of affiliation, partnership, or endorsement.

CapitalCityTickets.com is a reliable online marketplace serving the secondary market with tickets for all major concerts, sports, and theatre events. Online shoppers can take advantage of Promo Code “CITY5” while tickets last.

Check out the discount codes online for all upcoming events. CapitalCityTickets.com keeps low overheads which allow this trusted ticket site to keep prices competitive.

CapitalCityTickets.com | Live Customer Support | Order By Phone Toll Free | 7:00am-1:00am EST | (855) 514-5624

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/07/1436467814.jpeg

“Buy UCLA Bruins Football NCAA Tickets Online at CapitalCityTickets.com with Promo Code”

Media Contact
Company Name: CapitalCityTickets.com
Contact Person: Media Relations
Email: customerservice@capitalcitytickets.com
Phone: 1-855-514-5624
Country: United States
Website: http://www.capitalcitytickets.com/UCLA-Bruins-Football-Tickets

Source: ABNewswire

ReleaseID: 32298

Heat Biologics: Immunotherapy Vaccine to Transform Cancer Treatment

NEW YORK, NY / ACCESSWIRE / July 16, 2015 / We all
know that cancer affects many of our friends and family, but why don’t we all
get cancer? We now know that our immune
system is continuously fighting and destroying potential cancer cells.What if we could stimulate the immune system
in cancer patients and kill the tumor? This is exactly what Heat Biologics (NASDAQ: HTBX ) is doing.

Cancer is
a devastating disease and the harsh effects of current cancer treatments are
well-known to us all.A new way of
treating cancer known as immunotherapy is transforming cancer, not in the next
5 or 10 years, but today!And Heat
Biologics is playing a significant role in this new and exciting
landscape.Very simply put their drug
activates a patient’s cancer killing T-cells (immune cells) that seek and
destroy their tumor.

The way
cancer has been treated is essentially barbaric. Patients are injected with poisons known as
chemo that kill all cells, but kill cancer cells faster. Patients are bombarded with lethal radiation,
or useful organs infested with cancer are removed, leaving patients
incapacitated for the rest of their lives.

Driven by
its proprietary platform, ImPACT, Heat is developing multiple vaccines for a
number of different cancers. Vaccines have transformed polio, tetanus, chicken
pox and measles from being deadly diseases, to merely something we take a shot
for today. Cancer could become the next disease to be virtually eliminated by a
vaccine.

ImPACT
genetically modifies human cancer cells to pump out antigens (biological agents
that target the immune system) and proteins to create an immune response and
attack a specific cancer. Not like competitor’s drugs that take days, if not
weeks, to work, Heat’s therapy takes only a few minutes. Then the vaccine lives
at the site of the tumor, continuously targeting and destroying the
cancer.

Heat’s
vaccine platform is easy to make, stays on the shelf until needed, and can be
given to anybody, regardless of their blood type or DNA makeup, which is unique
in the cancer immunotherapy market. ImPACT is far superior to immunotherapies
offered by the global behemoths I will describe below, that need to use the
patient’s own tissue to make their products work – a costly and inconvenient
method.

Currently, Merck & Co. (MRK) is in line at the FDA with Keytruda,
first approved for skin cancer (with first
quarter sales of $83 million) hoping for approval in non-small cell lung cancer
(NSCLC) where analysts predict revenues upwards of $5 billion. Not to be shut
out by its giant competitor, Bristol-Myers Squibb Co.’s (BMY) Opdivo also began
on the market for skin cancer and was approved in March for NSCLC; after
only three months Opdivo generated sales of $40 million. Both
have severe side effects which I will explain below.

Joining
the ranks of these larger companies, Heat has an ongoing Phase II trial for its
HS-110 vaccine in the treatment of NSCLC. Heat is well positioned to compete for this
market expected
to be $7 billion globally by 2019, with a high annual growth rate.

In my recent
interview with Heat founder and CEO Jeffrey Wolf, I learned that instead of
using chemotherapy that destroys all human cells, ImPACT will direct its drugs
to kill cancer cells faster with immunotherapy that activates, stimulates, and
strengthens a patient’s immune system to attack a deadly disease with no known
cure. Besides lung cancer, Heat targets bladder cancer with HS-410, now in
Phase II at 16 US clinical sites (including Johns Hopkins, known for its
extensive urological work) to potentially enter a market estimated
at $300 million in the next two years. Expected completion of enrollment for the bladder cancer trial is the
third quarter of next year.

One problem I discussed with Mr. Wolf were side effects of the new anti-cancer
wonder drugs that have the potential of pneumonia, holes in intestines,
hepatitis and kidney failure. Newer companies like Kite Pharma (KITE) and Juno
Therapeutics (JUNO), two much-watched darlings of the cancer immunotherapy
world, trade at a combined valuation of $7.5 billion. Both target blood cancers
but Heat is testing patients much later than Juno for lung cancer. Juno and
Kite have shown in trials to lead to an overload of the immune system, known as
a deadly cytokine storm; high fever; and serious drops in blood pressure. Medical sources claim cancer immunotherapy drugs like those of Merck and
Bristol-Myers work in only 40% of patients and we will see how they fare in
lung cancer.

The
grandfather of cancer immunotherapy, Dendreon Corp’s (DNDN), drug Provenge
sales were limited
due to the cost to the patient which was approximately $93,000, leading the
company to declare bankruptcy. The complexity of customizing the drug for each
patient was too expensive.This will not
happen to Heat. Heat’s drug is an off the shelf product, so the cost per
patient is approximately $200 for a far superior product, enabling Heat to
generate pharmaceutical grade margins, according to Wolf.

Another major coming on board to
battle in the cancer immunotherapy space for NSCLC dollars is Eli Lilly &
Co. (LLY), but the FDA is wary. Recently, the agency met with Lilly to raise concerns
about deadly blood clots. Early data showed an extension of life slightly below
Merck’s or Bristol-Meyers – a median survival of just under one year. The drug,
if approved, is expected to make around $600 million per year but with almost
10% of patients developing what could turn into a heart attack, I’m sure the
FDA will be extra cautious.

Regardless, all sales projections
discussed above make for a lucrative story for Heat.
Heat’s NSCLC trials show excellent
safety profiles with good efficacy. HS-110 activated a strong immune response
in 70% of patients, including even those far along in their disease, leading to
a substantial increase in survival – up to 300% over chemotherapy. The Phase II
trial should finish enrolling patients in Q3 2015 and data is expected to be
reported later in 2016.
Despite adverse effects from Big (and smaller) Pharma
cancer immunotherapy drugs, the industry is projected to generate $35
billion in sales over the next ten years and used to treat 60% of cancers,
according to analysts, who believe immunotherapy will cause a tectonic shift in
how oncologists view cancer therapy.

Experts believe cancer immunotherapy will
make current anti-cancer methods primitive (some say barbaric) as we do away
with flooding the body with toxic chemotherapy and removing vital organs
through surgery.
Primitive is the word Dr.
Mark Schoenberg, key opinion leader to Heat also
serving on its clinical advisory board uses to describe current methods of
treating bladder cancer (which affects over 500,000 Americans and is one of the
most expensive
cancers to treat). Standard of care is to the attack disease through surgery,
not an optimal choice for the patient because bladder tissue does not grow
back. I learned from him there are no new drugs for bladder cancer, with most
doctors using BCG – a brutal tuberculosis vaccine originating more than 40
years ago. Male patients, as most are, need a catheter inserted directly into
the penis with unpleasant effects like pus formation and skin peeling.

Foremost immunologists in the world,
Dr. Eckhard Podack, is ImPACT’s inventor and serves as chairman of Heat’s
scientific advisory board. His work is in virtually every immunology textbook;
he has a track record of developing drugs that have gained FDA approval.For example, Seattle Genetics, Inc.’s (SGEN)
main drug Adcetris for lymphoma, has driven Seattle’s $6 billion market cap.
This came out of Dr. Podack’s lab.

There are several news-related
milestones for Heat coming up in the second half of 2015. I look forward to Phase II data in
NSCLC, because many eyes on Wall Street are focused on this indication.

Heat is a promising therapy, and in
line with industry trends, where larger drug companies invest a lot of money in
cancer immunotherapy. Celgene Corp. (CELG) just spent
$1 billion in a licensing deal with Juno that extends for 10 years, with a possible
30% ownership of Juno’s stock, what analysts are calling the largest
biotechnology deal ever.After the
announcement, Juno’s shares popped 66%, underscoring the love investors have
for immunotherapy.

Immunotherapy
can be the answer to bring cancer treatment into the modern age – from a deadly
disease into one open for long-term survival, like what pharma companies did
for diabetes. Allied Market Research projects
the global cancer drug market to reach $111.9
billion by 2020, with immunotherapy and biological drugs the main driver of
growth. This is what’s driving cancer immunotherapy drug companies’ high
values.

As of March 31, Heat had
approximately $21.1 million in cash, cash equivalents, and short-term
investments, providing a runway to take it through the first quarter of 2016.
With a market cap of $53 million, recent trading at a per share price of
between $6 to $7, Heat has an unjustifiably low valuation and I believe it is
poised to at least double in the short term. I’m not alone in this prognosis,
as the two firms covering the stock have price targets of $13 and $22 per
share.

Heat is a home-run from an
efficacy/safety and economic point of view.The stock offers a
phenomenal find for those looking for a lot of upside in cancer immunotherapy,
which is now characterized by companies with billion dollar market caps.

RAY
DIRKS suggests that Readers/Investors place no more than 1% of the funds they
devote to common stocks in any one issue. It’s best to diversify.

Contact:

Jackie Rodriguez
jackie@jvprny.com

SOURCE: RAY DIRKS Research

ReleaseID: 430612

DigiPath (DIGP) Well Positioned to Take Advantage of $850M Cannabis Testing Market

WHITEFISH, MT / ACCESSWIRE / July 16, 2015 / There are many different ways to profit from the burgeoning cannabis industry, ranging from GrowBLOX Sciences Inc.’s (OTCQB: GBLX) growing solutions to Medbox Inc.’s (OTCQB: MDBX) dispensing technologies to Cannabis Science Inc.’s (OTCQB: CBIS) focus on the medicinal properties of the plant, but cannabis testing could be the most compelling.

Cannabis testing is expected to generate close to a billion dollars in revenue by 2020, according to a new report by GreenWave Advisors, a comprehensive independent research firm focused on the emerging legal cannabis industry.

“It’s an exciting time to be in lab testing, because it’s one of the subsectors within the cannabis industry that we believe is sustainable as laws change,” said GreenWave Advisors Founder Matthew Karnes. “We view this as the most attractive subsector of the industry.”

Mr. Karnes points to a number of factors that make lab testing such an attractive subset of the emerging industry. While there’s a large initial investment required to establish a lab, which effectively creates a barrier to entry for competitors, existing labs operate with gross margins of between 60% and 65% with predictable recurring revenue driving strong free cash flow. The expansion of services beyond testing – into things like data analytics and consulting – could push these margins closer to the software industry’s 90%+ gross margins.

Ample Room For Growth

“We expect a little north of five million pounds of marijuana to be tested by 2020, which transcends into about $565 million [in lab testing revenue],” said Mr. Karnes. “And then, if you gross that up for other services – the data analytics and consulting – you get north of $850 million. But, it’s likely that our estimates are conservative, because testing will become less significant as a part of the total revenue mix as time goes on.”

GreenWave Advisors sees the market as very bifurcated at the moment, with regulations varying between states and no consistent national framework; however, the firm believes these dynamics will change as the industry matures. Mr. Karnes projects that large existing cannabis labs will be the biggest winners in the space, as they reach economies of scale, while smaller labs will be forced to consolidate or go out of business.

DigiPath (OTCQB: DIGP) Labs Actively Testing Product

The initial DigiPath lab is located in Southern Nevada and targets the booming City of Las Vegas, which is expected to benefit handsomely from the recent legalization of medical marijuana. With a program that supports reciprocity, out-of-state medical marijuana users will be able to access medicine during their trip to Las Vegas, and with over 40 million visitors a year to Las Vegas, sales are expected to be brisk.

“We opened our flagship lab about 35 days ago and we’re one of only two labs open in Southern Nevada,” said DigiPath Inc. CEO Todd Denkin. “Our plan is to duplicate this lab in all states where marijuana has been legalized.”

“The Department of Health has predicted that 540,000 pounds of marijuana will need to be grown to meet demand in the State of Nevada,” said Mr. Denkin. “Right now, we are going to focus in on the Las Vegas market and figure out how the market moves to see if we need to open something in Northern Nevada.”

While Las Vegas represents a compelling near-term opportunity, the company’s long-term goal is to expand into all states where marijuana has been legalized in order to become a predominant leader in the cannabis testing space.

“We are exploring different opportunities in various states right now,” says Denkin. “We are looking for maybe some struggling labs or maybe some up and coming labs as well. Our plan is to either buy or acquire or just go ahead and apply ourselves in these states.”

Cannabis investors may want to take a look at DigiPath as a leading player in the rapidly growing cannabis testing industry.

For more information, visit www.digipath.com. To learn more about it’s recently opened Nevada-based laboratory and potential expansion opportunities ahead visit www.digipathlabs.com.

Legal Disclaimer:

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Important factors that could cause these differences include, but are not limited to, the demand for the company’s services and the company’s ability to execute its business plan. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claim to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, has been compensated for its services in the form of cash and equity securities by DigiPath. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

SOURCE: Cannabis Financial Network

ReleaseID: 430613

Blonder Tongue Remembers Founder Ben H. Tongue

8:OLD BRIDGE, NJ / ACCESSWIRE / July 16, 2015 / Blonder Tongue Laboratories, Inc. (NYSE MKT: BDR) is saddened to report the passing of one of the company’s founders, Ben H. Tongue, who died in his sleep early the morning of July 4, 2015. Tongue graduated with an Electrical Engineering degree from Northeastern University in 1945 and a Masters from Polytechnic Institute of Brooklyn in 1948. Shortly thereafter, it was while working at Panoramic Radio Corporation that he met Ike Blonder and incorporated Blonder Tongue Laboratories in 1950. Each had the initiative to pioneer their efforts in both CATV and over-the-air television. Both gentlemen individually and together received 30 patents, numerous awards, and industry recognition.

 

“Ben H. Tongue was not only the founder, but also a comrade and good friend,” said Bob Palle, President of Blonder Tongue Laboratories. “It was the combination of Ben’s innovative ideas and rugged, reliable and cost effective products produced by the company that were the deciding factors to purchase the company back in 1989. My partner, Jim Luksch, (now retired) and I continued down the path previously paved by Ben and Ike to deliver top quality system solutions and equipment at a reasonable price.”

Blonder Tongue Laboratories, Inc. and of its employees offer their best wishes and condolences to Ben’s family.

About Blonder Tongue

Blonder Tongue Laboratories, Inc. together with R. L. Drake Holdings, LLC – its wholly owned subsidiary – offer customers more than 130 years of combined engineering and manufacturing excellence with solid histories of delivering reliable, quality products. As a leader in the field of Cable Television Communications, the Company provides system operators and integrators serving the cable, broadcast, satellite, IPTV, institutional and professional video markets with comprehensive solutions for the provision of content contribution, distribution and video delivery to homes and businesses. The Company designs, manufactures, sells and supports an equipment portfolio of standard and high definition digital video solutions, as well as core analog video and high speed data solutions for distribution over coax, fiber and IP networks. Additional information on the Company and its products can be found at www.blondertongue.com, and www.rldrake.com.

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: The information set forth above includes “forward-looking” statements and accordingly, the cautionary statements contained in Blonder Tongue’s Annual Report and Form 10-K for the year ended December 31, 2014 (See Item 1: Business, Item 1A: Risk Factors, Item 3: Legal Proceedings and Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations), and other filings with the Securities and Exchange Commission are incorporated herein by reference. The words “believe,” “expect,” “anticipate,” “project,” “target,” “intend,”, “plan,” “seek,” “estimate,” “endeavor,” “should,” “could,” “may,” and similar expressions are intended to identify forward-looking statements. In addition, any statements that refer to projections for our future financial performance, our anticipated growth trends in our business and other characterizations of future events or circumstances are forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. Blonder Tongue undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. Blonder Tongue’s actual results may differ from the anticipated results or other expectations expressed in Blonder Tongue’s “forward-looking” statements.

Contacts:

Bob Palle
CEO and President 
bpalle@blondertongue.com
732-679-4000

SOURCE: Blonder Tongue Laboratories, Inc.

ReleaseID: 430637